% alzhub.org topic: clinical-trials
% Source: https://alzhub.org/topic/clinical-trials
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{oosthoek2024-38678292,
  author  = {Oosthoek, M. and Vermunt, L. and de Wilde, A. and Bongers, B. and Antwi-Berko, D. and Scheltens, P. and van Bokhoven, P. and Vijverberg, E. G. B. and others},
  title   = {{Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01456-1},
  pmid    = {38678292},
  url     = {https://doi.org/10.1186/s13195-024-01456-1}
}

@article{ferreira2023-36878697,
  author  = {Ferreira, P. C. L. and Ferrari-Souza, J. P. and Tissot, C. and Bellaver, B. and Leffa, D. T. and Lussier, F. and Povala, G. and Therriault, J. and others},
  title   = {{Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207115},
  pmid    = {36878697},
  url     = {https://doi.org/10.1212/wnl.0000000000207115}
}

@article{obryant2023-35235702,
  author  = {O'Bryant, S. E. and Petersen, M. and Hall, J. and Johnson, L. A. and {HABS-HD Study Team}},
  title   = {{Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2023},
  doi     = {10.1002/alz.12647},
  pmid    = {35235702},
  url     = {https://doi.org/10.1002/alz.12647}
}